on behalf of the IDEFICS and I Family Consortia OBJECTIVES: The development of effective strategies to prevent childhood obesity and its comorbidities requires new, reliable early biomarkers. Here, we aimed to identify in peripheral blood cells potential transcript-based biomarkers of unhealthy metabolic profile associated to overweight/obesity in children. METHODS: We performed a whole-genome microarray analysis in blood cells to identify genes differentially expressed between overweight and normal weight children to obtain novel transcript-based biomarkers predictive of metabolic complications. RESULTS: The most significant enriched pathway of differentially expressed genes was related to oxidative phosphorylation, for which most of genes were downregulated in overweight versus normal weight children. Other genes were involved in carbohydrate metabolism/glucose homoeostasis or in lipid metabolism (for example, TCF7L2, ADRB3, LIPE, GIPR), revealing plausible mechanisms according to existing biological knowledge. A set of differentially expressed genes was identified to discriminate in overweight children those with high or low triglyceride levels. CONCLUSIONS: Functional microarray analysis has revealed a set of potential blood-cell transcript-based biomarkers that may be a useful approach for early identification of children with higher predisposition to obesity-related metabolic alterations.
INTRODUCTION
Obesity is nowadays considered one of the main public health problems, affecting not only adults but also children. WHO estimated that 42 million children under the age of 5 were overweight or obese in 2013. 1 What is even more worrying is the greater probability of an obese child to maintain obesity into adulthood. Moreover, early onset of obesity is associated with an increased incidence of comorbidities, such as type 2 diabetes, non-alcoholic fatty liver disease, cardiovascular diseases and metabolic syndrome. 2, 3 Knowing that obesity is influenced by several genetic, environmental and behavioural factors, and that the success of treatment is limited, prevention of obesity at early ages becomes a major need and should be one of the main focuses of attention. Thus, early diagnosis seems important for management and prevention of childhood obesity. The identification of biomarkers of predisposition to obesityassociated metabolic alterations could aid present/current strategies in decreasing in a more effective manner obesity-associated comorbidities, by targeting the underlying processes.
Transcriptome analysis in peripheral blood cells (PBCs), considering whole peripheral blood or a subpopulation of white blood cells, the so-called peripheral blood mononuclear cells (PBMCs), has been proposed as a research strategy to identify new biomarkers and candidate-genes for a number of diseases based on differentially expressed mRNA profiles. [4] [5] [6] [7] PBCs have the advantage of being easy to collect, unlike invasive biopsies. Moreover, gene expression in these cells may reflect the responses of internal organs, such as adipose tissue and liver, and thereby have been proposed as a source of biomarkers of health and disease. [8] [9] [10] More specifically, PBCs have been proposed as an appropriate method for studying the cardiovascular system, 6 or as a source of transcript-based biomarkers for very early stages of acute coronary disease. 5 In addition, the suitability of blood cells as a potential source for biomarkers of metabolic adaptations to food intake and body weight maintenance has been reported both in animal 8, 9, 11 and human studies. 12, 13 Besides, in murine models, expression levels of selected genes in PBCs have been proposed as predictive biomarkers of a healthy or distorted metabolic state because of interventions during the perinatal period. 14, 15 In the present study, a whole-genome microarray analysis was performed in PBCs to identify genes differentially expressed between overweight and normal weight children, using a crosssectional design, to derive novel transcript-based biomarkers that could be predictive of metabolic complications in early life. These biomarkers could be helpful for identifying particularly those obese children who are at-risk of metabolic complications, hence allowing early interventions in a more effective way.
MATERIALS AND METHODS Participants
IDEFICS is a large European multi-centre study on childhood obesity (details in Ahrens et al.,
16
). Using a cross-sectional design, whole-genome 1 microarray analysis has been performed in PBCs from a subgroup of 32 individuals with normal weight 17 and overweight, 15 belonging to the Spanish IDEFICS cohort. Children included in the analysis were randomly selected within normal weight and overweight individuals and matched by sex. Body mass index (BMI) categories were defined according to Cole et al. 17 The age range was 4.7-8 years.
Blood sampling and processing for gene expression analysis
For each participant, a total of 2.5 ml peripheral blood was collected under fasting conditions into PAXgene vacutainer tubes (Qiagen, Izasa-Barcelona, Spain) via antecubital fossa venipuncture. Total RNA was isolated using the PAXgene blood RNA kit according to the manufacturer's instructions (Qiagen) and as previously described. 13 Microarray processing
From each sample, 80 ng of RNA was reverse transcribed to complementary DNA (cDNA) using the Agilent Low Input Quick Amp Labeling kit (Agilent Technologies, Santa Clara, CA, USA) according to the manufacturer's protocol. Then, half of the cDNA sample (10 μl) was used for the linear amplification of RNA and labelling with cyanine-3 (Cy3) or Cy5. Transcription and labelling were carried out at 40°C for 2 h. The labelled and amplified cRNA samples were purified using Qiagen Rneasy MiniSpin columns (Qiagen, Madrid, Spain). The incorporation of dyes and cRNA concentration was measured using the NanoDrop ND 1000 spectrophotometer (NanoDrop Techonologies, Wilmington, DE, USA). Then, 825 ng of cRNA labelled with Cy5 from each sample and 825 ng of Cy3 pool was hybridised on 4 × 44K G4845A human whole genome Agilent microarrays (Agilent Technologies) for 17 h at 65°C in hybridisation chambers in an oven rotating at 10 rpm (Agilent Technologies). After hybridisation, the arrays were washed with 'GE wash buffer 2' for 1 min at 37°C, followed by acetonitrile for 10 s at room temperature, and finally with a solution for stabilisation and drying for 30 s at room temperature, according to the manufacturer's protocol (Agilent Technologies).
Microarray data analysis
The arrays were scanned with an Agilent Microarray Scanner (Agilent Technologies). Scanned images were examined for visible defects and proper grid alignment. The intensities of the signals from each spot were quantified, and the raw data were extracted using Feature Extraction Software version 10.10.1.1 (Agilent Technologies). Background correction was performed by subtracting the background intensities from the foreground intensities. Normalisation within and between arrays was conducted using the loess method and the quantile method, respectively. All samples showed correct normalisation and were thus used in further statistical analysis.
The Babelomics 4.3 platform (http://babelomics.bioinfo.cipf.es), a suite of web tools for microarray data analysis, 18 was applied for statistical analysis. The patterns of probes matching for the same gene were merged, and hence obtaining the median. Next, differential gene expression between overweight and normal weight children was assessed by the Limma test. Fold changes were the difference in log2 mean values between experimental groups. The threshold of significance for this statistical test was set at Po0.01. To control for false positives we selected gene expression differences for a false discovery rate (FDR) 19 of 16%. Biological information of the identified genes was obtained in available databases (NCBI, UniProt, Genecards). In addition, to gain insight into biological mechanisms, pathway analysis was conducted using Metacore (GeneGo, Thomson Reuters, NY, USA). Genes with expression levels significantly different between normal weight and overweight children were plotted in a heat map using R (v 3.1.1, R Development Core Team). Partial least squares discriminant analysis (PLS-DA) was performed using the Excel addin Multibase (Numerical Dynamics, Tokyo, Japan) to select a more reduced number of gene transcripts to discriminate between overweight and normal weight subjects, with high and low metabolic risk.
Reverse transcription quantitative polymerase chain reaction analysis
To validate the results from the microarray analysis, mRNA expression levels of 10 selected genes were measured by reverse transcription quantitative polymerase chain reaction (RT-qPCR). These genes included the five genes from oxidative phosphorylation chain that displayed the greatest changes in the array analysis and other selected genes related to food intake control, signalling and carbohydrate metabolism (see Supplementary Table 1 for further details). RT-qPCR was performed as previously described. 13 Briefly, 0.25 μg of total RNA was denatured at 65°C for 10 min and then reverse transcribed to cDNA using MuLV reverse transcriptase at 20°C for 15 min, 42°C for 30 min, with a final step of 5 min at 95°C in an Applied Biosystems 2720 Thermal Cycler (Applied Biosystems, Madrid, Spain). Each PCR was performed from diluted (1/5) cDNA template, forward and reverse primers (1 mM each) and Power SYBER Green PCR Master Mix. Real-time PCR was performed using the Applied Biosystems StepOnePlus Real-Time PCR Systems with the following profile: 10 min at 95°C, followed by a total of 40 two-temperature cycles (15 s at 95°C and 1 min at 60°C). To verify the purity of the products, a melting curve was produced after each run according to the manufacturer's instructions. The threshold cycle (Ct) was calculated using the instrument's software (StepOne Software version 2.2.2, Applied Biosystems), and the relative expression of a target gene to a housekeeping gene was calculated. Tripartite motif containing 27 (TRIM27) was chosen as housekeeping gene because showed equal expression levels across all groups.
Statistical analysis
No blinding was carried out for data analysis. Data are presented as mean and the standard error of the mean (s.e.m.). The statistical analysis of microarray data was conducted as described above. Statistical analysis of the anthropometric and biochemical parameters was performed using SPSS version 20. The median value of each gene's expression distribution in the overall group was selected as an arbitrary cut-off point to group gene expressions in low and high expression categories. Levene's test was performed to assess whether the variance is equal between groups. Single comparisons between groups were assessed by Student's t-test. Two-way ANOVA was used to determine differences between BMI and gene expression categories (high versus low). Threshold of significance was defined at Po0.05.
RESULTS

Subject characteristics
Characteristics of the subjects included in the study are shown in Table 1 . The random sample consists of 32 children from the Spanish cohort of the IDEFICS study, uniformly distributed by weight and sex, and with a range of age between 4.7 and 8 years. Compared with normal weight, overweight children exhibited as expected higher body weight, BMI and BMI z-score, 20 subcutaneous fat (calculated as the sum of four different skin folds), waist/ 20 Subcutaneous fat represents the sum of four different skin folds (subscapular, biceps, triceps and suprailliac crest). Statistics: *, ** differences between overweight and normal weight children (Po0.05 and Po0.01, respectively, by Student's t-test).
Early biomarkers of metabolic alterations J Sánchez et al height ratio and HOMA-IR index, and also presented higher insulinaemia and triglyceridemia (P o 0.01, Student's t-test). No differences were found between normal weight and overweight children concerning total, HDL and LDL cholesterol levels. Mean age of overweight children was significantly higher than that of normal weight children.
Gene expression profiling in PBCs
Of the 45 220 probes tested in the microarray analysis, 29 094 probes remained after background correction, normalisation and merging replicated probes and were used for further analysis. In total, 1716 unique genes were found to be expressed significantly different between normal weight and overweight children (P o 0.01; Limma test). There were 550 unknown genes, 50 non coding genes and 39 were pseudogenes, and hence were not considered in the following steps. From the remaining 1077 known coding genes, 505 were downregulated and 572 upregulated in overweight compared to normal weight children.
The results from the array concerning the 1077 genes differently expressed between normal weight and overweight children across individual samples are depicted in a heat map (Figure 1 ).
Functional and biological analysis Using available databases (NCBI, UniProt and Genecards), the 1077 known genes with significantly different expression levels between normal weight and overweight children were classified into several biological processes according to their function (Supplementary Figure 1) . The biological processes showing the highest number of differentially expressed genes were related to transcription/translation machinery (n = 223), cell turnover (n = 123), signalling (n = 121), immune system (n = 78), metabolism of proteins (n = 56), transport (n = 53), metabolism of lipids (n = 50), nervous system (n = 45), central metabolism (n = 44) and cytoskeleton (n = 34). Other biological processes with a notable number of differently expressed genes (n = 12-30) were related to neural signalling, blood, sensory perception of taste and smell, metabolism of carbohydrates, redox metabolism, epigenetic modification, metabolism of amino acids and protein or lipid glycosylation. The remaining genes were related to the metabolism of nucleotides and amines, metabolism of vitamins and minerals, cell communication, food intake control and vascular homoeostasis (with 11 or less genes involved in each process). Other genes related to biological processes such as autophagy, cell-cell adhesion, collagen, keratins, extra cellular matrix and so on were grouped under 'miscellanea'. The set of 1077 known genes was further analysed for functional and biological pathways using the MetaCore platform (GeneGo). The top 10 pathway maps are listed in Table 2 . The most significant enriched pathway in our data set was related to mitochondrial oxidative phosphorylation. Notably, most of the genes involved in this pathway were downregulated in overweight compared to normal weight children. Results regarding the five genes related to oxidative phosphorylation displaying the greatest changes in the microarray analysis (ATP5O, NDUFS5, NDUFB8, COX6C and ATP1F1) were fully validated by RT-qPCR (Supplementary Table 1) .
Expression levels of genes involved in the tricarboxylic acid (TCA) cycle were also reassessed, as this process supplies NADH and succinate to oxidative phosphorylation. Notably, key genes in the TCA cycle were generally downregulated in overweight compared with the normal weight children, but particularly regarding succinate handling. This is the case of SUCLG2 (succinate-CoA ligase, GDP-forming, beta subunit), SDHB (succinate dehydrogenase complex, subunit B, integral membrane protein, 15 kDa), SDHC (succinate dehydrogenase complex, subunit C, integral membrane protein, 15 kDa) and MDH2 (malate dehydrogenase 2, NAD (mitochondrial)). Furthermore, genes encoding for two subunits of the pyruvate dehydrogenase (PDH) multi-enzyme complex, PDHB and PDHX, which catalyse the overall conversion of pyruvate to acetyl coenzyme and provide the primary link between glycolysis and the TCA cycle, were downregulated in overweight children compared with the normal weight children (P = 0.013 and P = 0.017, respectively, Limma test). Upregulated mRNA expression was also detected in overweight children for PC (pyruvate carboxylase), which catalyses carboxylation of pyruvate to form oxaloacetate.
Besides the above-mentioned, other differentially expressed genes between normal weight and overweight children are suggested as relevant regarding obesity-related metabolic alterations, according to existing biological knowledge. Among them are the transcription factor 7-like 2 (TCF7L2) and the gastric inhibitory polypeptide receptor (GIPR) (associated with carbohydrate metabolism and glucose homoeostasis) or the adrenergic, beta-3-, receptor (ADRB3) and the lipase, hormone-sensitive (LIPE) (associated with lipid metabolism).
Biomarker selection To refine intergroup differences between normal weight and overweight children, and select the most relevant and discriminatory genes with the greatest potential as biomarkers, data were also analysed with the PLS-DA. The set of 1077 genes was included in the analysis. PLS-DA score plot also showed a clear separation between normal weight and overweight children (Figure 2a ). We retained those 30 genes with the highest loading in PC1 and in PC2 (Supplementary Table 2 ) and carried out a new PLS-DA. We obtained a model with a clear separation between normal weight and overweight individuals (Figure 2b ). PC1 and PC2 accounted for 45.7 and 29.9% of the variance. The 10 variables that mostly contributed to the model, all of them included in the PC1, were zinc finger protein 418 (ZNF418), natriuretic peptide A (NPPA), polymerase (RNA) I polypeptide C, 30kDa (POLR1C), adrenergic, beta-3-receptor (ADRB3), purinergic receptor P2X, ligand-gated ion channel, 2 (P2RX2), dynein, axonemal, light chain 4 (DNAL4), neuronal signalling (cortistatin (CORT), trefoil factor 1 (TFF1), neuronal growth regulator 1 (NEGR1) and Interleukin 15 receptor, alpha (IL15RA) (Figure 2c ).
Association studies of gene expression with circulating triglyceride levels Children were grouped into categories (low/high) according to selected biochemical parameters, HOMA index, insulin and triglycerides (TG). The median value of each parameter's distribution in the overall group was selected as a cut-off point to define these categories. A new PLS-DA was built (including the 1077 genes differentially expressed between normal weight and overweight children) to identify genes that differentiate children according not only to their body weight, but also to their metabolic risk. Only the results obtained in PLS-DA for discrimination of children with high and low TG levels within normal weight and overweight children displayed a valid model (Supplementary Figure 2) . The PLS-DA showed that within normal weight children the model does not discriminate between those having high or low TG levels, because both groups are located in the quadrant with the higher score for PC1 (Figure 3) . However, this model shows better separation within overweight children (Figure 3 ). Overweight children with low TG levels were mainly located on the right side of PC1, as normal weight children. This suggests that Table 2 ). (c) Plot with variable loading from PLS-DA showed in C with the 10 variables that contributed the most to variability of individual expression data. PLS-DA analysis was performed using the Excel add-in Multibase package (Numerical Dynamics).
those genes with a high loading score in PC1 may be good candidates as biomarkers to discriminate between overweight children with high or low TG levels. The genes are listed in Supplementary Table 3 . It is noteworthy that the list of genes with high loadings in PC1 includes 8 of the 10 genes previously listed in Figure 2c (ZNF418, NPPA, POLR1C, ADRB3, P2RX2, DNAL4, CORT and TFF1) as those that mostly contributed to the separation between normal weight and overweight children. The discriminatory power of the expression profile of the above-mentioned genes on TG levels within overweight children was further studied by considering each individual gene (Figure 4 ). For that, normal weight and overweight children were subdivided according to their gene expression levels (low versus high) by using the median value of each gene expression's distribution of the whole sample as a cut-off point. Overweight children with high expression levels of most of the genes (ZNF418, NPPA, POLR1C, ADRB3, DNAL4, CORT and TFF1), exhibited higher TG levels than those with low expression levels (P o0.05, Student's t-test), whereas no differences were found in normal weight children. In the case of P2RX2, the trend was similar, but differences were not statistically significant.
DISCUSSION
To identify biomarkers that can be predictive of unhealthy metabolic alterations associated to overweight/obesity in children, we first performed a comparative analysis of the transcriptome profile in PBCs of normal weight and overweight children. Overall 1077 known coding genes differently expressed between these two groups of children were detected, clearly separated by both PLS-DA and the heat map. Microarray data were confirmed by RTqPCR performed for a selection of 10 genes. Pathway enrichment analysis revealed that the most significant enriched pathway was related to mitochondrial oxidative phosphorylation. Most of the genes involved in this pathway were downregulated in overweight compared to normal weight children. A reduction in the expression levels of genes involved in the oxidative phosphorylation has also been described in the Triglyceride levels in children with low and high expression levels of specific genes in blood cells. Genes selected were: ZNF418, NPPA, POLR1C, ADRB3, P2RX2, DNAL4, CORT or TFF1. Results are mean ± s.e. of the mean. Statistics: W, effect of BMI; E, effect of expression levels (low versus high), WxE, interactive effect of BMI and expression levels (P o0.05 two-way ANOVA); *P o0.05 high versus low expression levels (Student's t-test); P o0.05 overweight versus normal weight (Student's t-test).
skeletal muscle, 21, 22 visceral adipose tissue 23 and in PBMCs 24 from adult patients with type 2 diabetes. It has also been reported that the reduction in the set of genes involved in oxidative phosphorylation in PBMCs seems to be intrinsic to the diabetic state since altered expression was not changed by glycaemic control. 24 Notably, overweight children involved in the present study were not diagnosed with type 2 diabetes, although they displayed higher insulin levels and HOMA index values compared with the normal weight children with no alteration in fasting glucose levels. In addition, we also observed a parallel reduction in key genes of the TCA cycle and of genes encoding for two subunits of the pyruvate dehydrogenase complex, which catalyses the conversion of pyruvate to acetyl-CoA and provides the primary link between glycolysis and the TCA cycle. Conversely, pyruvate carboxylase, which catalyses the carboxylation of pyruvate to oxaloacetate, was upregulated in overweight children, suggesting that pyruvate may be driven to the conversion to oxaloacetate more than to acetyl-CoA. Overall, the expression level of key genes in PBCs pointed to a disturbed oxidative capacity in overweight children, which could reflect impairment in other internal tissues. This may be a hallmark of overweight/obesity, also indicative of a pre-diabetic state, regardless of an alteration in glucose levels.
Moreover, also in reference to type 2 diabetes, differences in the expression levels of transcription factor 7-like 2 (TCF7L2) may be of potential interest. TCF7L2 is a key regulator of (pro)insulin synthesis and processing.
25 TCF7L2 harbours common genetic variants (particularly the single-nucleotide polymorphism rs7903146) with the strongest and most widely replicated effect on type 2 diabetes risk already described. 26, 27 The risk T-allele of rs7903146 has been associated with impaired glucose-stimulated insulin secretion and processing and increased insulin resistance, 28 and carriers of the T-allele have been reported to display increased expression of TCF7L2 in human pancreatic islets. 29 The frequency of the risk T-allele has been found to be higher not only in diabetic patients, but also in those who develop macro-vascular complications. 30 Moreover, centenarians show the lowest frequency of T-allele and the highest frequency of C-allele, which emerges as a protective longevity variant. 30 Notably, in the present study, TCF7L2 has been identified as one of the genes differently expressed between normal weight and overweight children, being upregulated in overweight children. These results might suggest a higher presence of the risk T-allele in overweight individuals, although this has not been addressed here since it was not the objective of the study. In any case, present findings show that greater TCF7L2 expression levels in PBCs, regardless of the polymorphism variant, may by indicative of higher risk of obesity and diabetes in children.
PLS-DA is considered a powerful and simple tool for analysing microarray data that allows to predict the phenotype given the expression levels. 31 Here, PLS-DA was successfully applied to select a more reduced number of gene transcripts to discriminate between overweight and normal weight subjects. The 10 genes, whose transcripts have been identified as most relevant to the discrimination between overweight and normal weight children in our PLS-DA model, were related to metabolism (ADRB3), nervous system (NEGR1), neuronal signalling (CORT and P2RX2), signalling (IL15RA), vascular homoeostasis (NPPA), transcription/translation machinery (POLR1C and ZNF418), cytoskeleton (DNAL4) and TFF1. mRNA levels of all of them were upregulated in PBCs of overweight compared with the normal weight children. Moreover, using a new PLS-DA model, we defined a set of genes whose expression levels may discriminate between overweight individuals with high or low TG levels. It is worth noting that the latter set of genes includes 8 of the list of 10 genes above-mentioned (ZNF418, NPPA, POLR1C, ADRB3, P2RX2, DNAL4, CORT and TFF1).
Other genes with a relevant role in lipid metabolism (such as LIPE), or glucose homoeostasis (such as GIPR) are also included. Both genes were also upregulated in overweight children.
Some genes identified as candidate biomarkers in both PLS-DA models seem to be especially remarkable in terms of biological plausibility regarding body weight and metabolic aspects. Particularly, ADRB3 is related to lipid metabolism. The ADRB3 gene encodes for the adrenergic receptor beta-3, which is mainly present in adipose tissue and involved in the regulation of lipolysis and thermogenesis. A single-nucleotide polymorphism in the coding region of this gene has been associated with childhood obesity and other features of the metabolic syndrome. 32 In addition, genome-wide association studies have identified sequence variants of loci near to NEGR1 and GIPR associated with BMI. [33] [34] [35] GIPR encodes a G-protein coupled receptor for gastric inhibitory polypeptide (GIP). GIP is well known for its insulin tropic action and its secretion is stimulated by both fat and glucose. 36 In mice, knock-out or antagonism of GIPR protects from obesity and metabolic abnormalities, such us insulin resistance induced by the consumption of a high-fat diet. 37, 38 In humans, GIP has been shown to increase adipose tissue expression and plasma concentration of MCP-1 and seems to promote a crosstalk between macrophages and adipocytes to induce an inflammatory response associated to high-density food intake and obesity. 39 Regarding NEGR1, the protein encoded by this gene is a cell adhesion molecule expressed in different areas of central nervous system. Experimental data with NEGR1-deficient mice showed that the loss of function of NEGR1 has negative consequences on body mass and produces a reduction in food intake, although the mechanisms involved are still unknown. 40 In humans, the at-risk allele of the associated variant (rs2568958) has been related to increased expression (per allele copy) of NEGR1 in blood, 34 pointing that upregulation of NEGR1 in human may be associated to increased BMI. 40 CORT may also be of potential interest. This gene encodes for the cortistatin (CORT) neuropeptide, which shares high structural and functional similarities with somatostatin (SST). In addition to their roles in the central nervous system, both peptides also regulate endocrine secretion. CORT has been shown to bind with high affinity to the ghrelin receptor (GHSR) and have important actions on pancreatic function. 41 In islets isolated from C57BL6 mice, CORT action has been reported to reduce the glucose-stimulated insulin secretion. 42 Therefore, the presence of higher expression levels of this gene in PBCs from overweight children may also be in agreement with a greater predisposition to type 2 diabetes.
Despite the care taken in selecting the study cohort to have a similar number of normal weight and overweight children within the range of age considered, the study has the limitation that the mean age of the overweight group is significantly higher than that of the normal weight group. Although it is not expected that the age difference is responsible for the differences found between groups, it does lead to limitations in the interpretation of the results that may be considered in further studies. Another fact to take into account is the use of the whole fraction of blood cells, instead of PBMC sub-populations, because this provides methodological advantages. Therefore, differences in PBMC subpopulations could be masking some changes in gene expression that could be used as early biomarkers. Finally, the cross-sectional nature of the study may also be considered as a limitation, as it may not provide definite information on cause-and-effect relationships. The predictive value of the identified biomarkers needs further validation in follow-up studies.
In summary, functional microarray analysis of PBCs from normal weight and overweight children has revealed early changes associated to overweight, indicative of a reduced capacity of metabolic handling through the TCA cycle and oxidative phosphorylation, which, if generalised to other tissues, may contribute to the energy imbalance and later metabolic disorders. Moreover, other genes related with glucose homoeostasis and lipid metabolism revealed other putative mechanisms according to biological knowledge. With a PLS-DA model, a set of potential transcript-based biomarkers has been identified that, once validated in future studies, may be a useful approach for early identification of children with higher predisposition to obesity and its related metabolic alterations, particularly in terms of insulin resistance and hypertriglyceridemia. However, due to the crosssectional nature of the analysis, the predictive value of the identified biomarkers should be considered with some reservations and requires verification.
